Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EG017 Ointment Phase II Study in Dry Eye Disease
CTR20232682Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Aug 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EG-017 in dry eye syndrome (DED), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Aug 2023; status: completed.
02
Drugs
EG-017
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20232682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232682.